Found: 37
Select item for more details and to access through your institution.
Combination bezafibrate and nivolumab treatment of patients with advanced non–small cell lung cancer.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 675, p. 1, doi. 10.1126/scitranslmed.abq0021
- By:
- Publication type:
- Article
Recurrence patterns and progression-free survival after chemoradiotherapy with or without consolidation durvalumab for stage III non-small cell lung cancer.
- Published in:
- Journal of Radiation Research, 2023, v. 64, n. 1, p. 142, doi. 10.1093/jrr/rrac057
- By:
- Publication type:
- Article
Usefulness of pro-gastrin-releasing peptide as a predictor of the incidence of brain metastasis and effect of prophylactic cranial irradiation in patients with limited-stage small-cell lung cancer.
- Published in:
- Journal of Radiation Research, 2022, v. 63, n. 4, p. 636, doi. 10.1093/jrr/rrac035
- By:
- Publication type:
- Article
CD47 polymorphism for predicting nivolumab benefit in patients with advanced non-small-cell lung cancer.
- Published in:
- Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13950
- By:
- Publication type:
- Article
Sarcomatoid malignant pleural mesothelioma treated with nivolumab: A case series.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
YAP1 mediates survival of ALK-rearranged lung cancer cells treated with alectinib via pro-apoptotic protein regulation.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-019-13771-5
- By:
- Publication type:
- Article
Disease Flare after Discontinuation of Crizotinib in Anaplastic Lymphoma Kinase-Positive Lung Cancer.
- Published in:
- Case Reports in Oncology, 2013, v. 6, n. 2, p. 430, doi. 10.1159/000354756
- By:
- Publication type:
- Article
Adaptive resistance to lorlatinib via EGFR signaling in ALK-rearranged lung cancer.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00350-7
- By:
- Publication type:
- Article
Thyroid metastasis of pulmonary adenocarcinoma with EGFR G719A mutation: Genetic confirmation with liquid‐based cytology specimens.
- Published in:
- Cytopathology, 2021, v. 32, n. 3, p. 364, doi. 10.1111/cyt.12940
- By:
- Publication type:
- Article
MCL1 inhibition is effective against a subset of small-cell lung cancer with high MCL1 and low BCL-XL expression.
- Published in:
- Cell Death & Disease, 2020, v. 11, n. 3, p. 1, doi. 10.1038/s41419-020-2379-2
- By:
- Publication type:
- Article
A phase lotal study of five peptides combination with oxaliplatin-based chemotherapy as a first-line therapy for advanced colorectal cancer (FXV study).
- Published in:
- Journal of Translational Medicine, 2014, v. 12, n. 1, p. 1, doi. 10.1186/1479-5876-12-108
- By:
- Publication type:
- Article
A phase ΙI study of five peptides combination with oxaliplatin-based chemotherapy as a first-line therapy for advanced colorectal cancer (FXV study).
- Published in:
- 2014
- By:
- Publication type:
- journal article
Phase II Study of Consolidation Amrubicin After Concurrent Chemoradiotherapy in Patients With Limited-stage Small-cell Lung Cancer.
- Published in:
- In Vivo, 2020, v. 34, n. 2, p. 897, doi. 10.21873/invivo.11855
- By:
- Publication type:
- Article
Immune checkpoint inhibitors in patients with lung cancer having chronic interstitial pneumonia.
- Published in:
- ERJ Open Research, 2024, v. 10, n. 2, p. 1, doi. 10.1183/23120541.00981-2023
- By:
- Publication type:
- Article
Therapeutic strategy for non-small-cell lung cancer patients with brain metastases (Review).
- Published in:
- Biomedical Reports, 2013, v. 1, n. 5, p. 691, doi. 10.3892/br.2013.151
- By:
- Publication type:
- Article
Clinical impact of low serum free T4 in patients with non-small cell lung cancer treated with nivolumab.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-53327-7
- By:
- Publication type:
- Article
Successful treatment of lung cancer coexisting with B‑cell lymphoma with pembrolizumab following rituximab‑included chemotherapy: A case report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Retrospective analysis of acute exacerbation of interstitial lung diseases with nanoparticle albumin-bound paclitaxel in patients with advanced lung cancer with preexisting interstitial lung disease.
- Published in:
- Molecular & Clinical Oncology, 2017, v. 7, n. 4, p. 677, doi. 10.3892/mco.2017.1373
- By:
- Publication type:
- Article
Successful oral desensitization with crizotinib after crizotinib-induced hepatitis in an anaplastic lymphoma kinase-rearranged non-small-cell lung cancer patient: A case report.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Albumin-bound paclitaxel for the treatment of refractory or relapsed small-cell lung cancer.
- Published in:
- Molecular & Clinical Oncology, 2016, v. 5, n. 1, p. 213, doi. 10.3892/mco.2016.887
- By:
- Publication type:
- Article
Response to chemotherapy with carboplatin plus albumin-bound paclitaxel in a patient with lymphoepithelioma-like thymic carcinoma: A case report.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Effect of liver toxicity on clinical outcome of patients with non-small-cell lung cancer treated with pemetrexed.
- Published in:
- Molecular & Clinical Oncology, 2015, v. 3, n. 2, p. 334, doi. 10.3892/mco.2014.452
- By:
- Publication type:
- Article
Author Correction: Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancer.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Performance status improvement and advances in systemic treatment after brain metastases resection: a retrospective single-center cohort study of non-small cell lung cancer patients.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12798-2
- By:
- Publication type:
- Article
Management and Outcomes of Newly Diagnosed Non-Small Cell Lung Cancer Patients with Brain Metastases: A Real-World Study in Japan.
- Published in:
- Oncology, 2020, v. 98, n. 7, p. 460, doi. 10.1159/000506368
- By:
- Publication type:
- Article
Subjective symptoms are triggers for the detection of immune checkpoint inhibitor-induced interstitial lung disease and associate with disease severity: a single-center retrospective study.
- Published in:
- Journal of Pharmaceutical Health Care & Sciences, 2024, v. 10, n. 1, p. 1, doi. 10.1186/s40780-024-00373-7
- By:
- Publication type:
- Article
Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancer.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-03139-5
- By:
- Publication type:
- Article
Yes‐associated protein 1 mediates initial cell survival during lorlatinib treatment through AKT signaling in ROS1‐rearranged lung cancer.
- Published in:
- Cancer Science, 2023, v. 114, n. 2, p. 546, doi. 10.1111/cas.15622
- By:
- Publication type:
- Article
Significance of c- MET overexpression in cytotoxic anticancer drug-resistant small-cell lung cancer cells.
- Published in:
- Cancer Science, 2014, v. 105, n. 8, p. 1032, doi. 10.1111/cas.12447
- By:
- Publication type:
- Article
ABCC11/MRP8 confers pemetrexed resistance in lung cancer.
- Published in:
- Cancer Science, 2010, v. 101, n. 11, p. 2404, doi. 10.1111/j.1349-7006.2010.01690.x
- By:
- Publication type:
- Article
Significance of thymidylate synthase for resistance to pemetrexed in lung cancer.
- Published in:
- Cancer Science, 2010, v. 101, n. 1, p. 161, doi. 10.1111/j.1349-7006.2009.01358.x
- By:
- Publication type:
- Article
Analgesic Effect of Switching From Oral Opioids to a Once-a-Day Fentanyl Citrate Transdermal Patch in Patients With Lung Cancer.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Phase II Study of Pemetrexed and Erlotinib in Pretreated Nonsquamous, Non-Small-Cell Lung Cancer Patients without an EGFR mutation.
- Published in:
- Chemotherapy (0009-3157), 2014, v. 59, n. 6, p. 414, doi. 10.1159/000363731
- By:
- Publication type:
- Article
Organic cation transporter OCT6 mediates cisplatin uptake and resistance to cisplatin in lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 985, doi. 10.1007/s00280-015-2723-x
- By:
- Publication type:
- Article
Over-expression of MDR1 in amrubicinol-resistant lung cancer cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 3, p. 669, doi. 10.1007/s00280-010-1533-4
- By:
- Publication type:
- Article
Trochlear nerve schwannoma with concomitant osimertinib-responsive stage IV lung adenocarcinoma: illustrative case.
- Published in:
- Journal of Neurosurgery Case Lessons, 2024, v. 8, n. 7, p. 1, doi. 10.3171/CASE24144
- By:
- Publication type:
- Article
Clinical Impact of Single Nucleotide Polymorphism in PD-L1 on Response to Nivolumab for Advanced Non-Small-Cell Lung Cancer Patients.
- Published in:
- Scientific Reports, 2017, p. 45124, doi. 10.1038/srep45124
- By:
- Publication type:
- Article